comprehensive -WSS

comprehensive

author：leisure time 2025-09-30 01:19:46 - browse：68469

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Drug companies' payments and gifts affect physicians' prescribing

WSS

Covid silver lining: Unprecedented look at human immune system

Multiple sclerosis has subtypes with different best treatments: study

'Ancient DNA,' 23andMe reveal African American ancestries

Researchers test human milk's ability to repair gut microbiome

Oral obesity drug from Viking Therapeutics hits key early target

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

leisure time

comprehensive

leisure time

Continuity nursing helped my family in our darkest PICU moments

Trial using CRISPR to edit HIV out of cells disappoints

New air purifier tech could be key to improving indoor air quality

Four alarming medical procedures we’re glad history forgot

Trump demands the U.S. pay no more for drugs than other countries … again

U.K. decision on ALS drug has neurologists, advocates up in arms

State Dept. review finds Biden bears some blame for Afghanistan failures

Dramatically reducing cancer deaths requires the PASTEUR Act

Peter Hotez and the public health issue of online harassment

ProMED, early warning system on disease outbreaks, in peril

explore

Alzheimer's risk factor APOE4 may be a distinct form of the disease

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

What the cancer research community can learn from the Covid response

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

My superpower is killing ticks

Nearly two

Wikipedia

Wikipedia

focus

leisure time